Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The 'good', the 'bad', and the 'ugly' rectal cancers.

Literature DB >> 18097776

The 'good', the 'bad', and the 'ugly' rectal cancers.

Lennart Blomqvist, Bengt Glimelius.

Abstract

Entities: Disease

Mesh：

Year: 2008 PMID： 18097776 DOI： 10.1080/02841860701802585

Source DB: PubMed Journal: Acta Oncol ISSN： 0284-186X Impact factor: 4.089

Keyword Cloud
Cited

× No keyword cloud information.

25 in total

1. Systemic Chemotherapy as Salvage Treatment for Locally Advanced Rectal Cancer Patients Who Fail to Respond to Standard Neoadjuvant Chemoradiotherapy.

Authors: Francesco Sclafani; Gina Brown; David Cunningham; Sheela Rao; Paris Tekkis; Diana Tait; Federica Morano; Chiara Baratelli; Eleftheria Kalaitzaki; Shahnawaz Rasheed; David Watkins; Naureen Starling; Andrew Wotherspoon; Ian Chau
Journal: Oncologist Date: 2017-05-05

2. Human cytomegalovirus and Epstein-Barr virus infection impact on (18)F-FDG PET/CT SUVmax, CT volumetric and KRAS-based parameters of patients with locally advanced rectal cancer treated with neoadjuvant therapy.

Authors: Claudio V Sole; Felipe A Calvo; Carlos Ferrer; Emilio Alvarez; Jose L Carreras; Enrique Ochoa
Journal: Eur J Nucl Med Mol Imaging Date: 2014-10-01 Impact factor: 9.236

3. ¹⁸F-FDG PET/CT-based treatment response evaluation in locally advanced rectal cancer: a prospective validation of long-term outcomes.

Authors: Felipe A Calvo; Claudio V Sole; Dolores de la Mata; Luis Cabezón; Marina Gómez-Espí; Emilio Alvarez; Paz Madariaga; José L Carreras
Journal: Eur J Nucl Med Mol Imaging Date: 2013-02-23 Impact factor: 9.236

4. The good, the bad and the ugly: rectal cancers in the twenty-first century.

Authors: G P São Julião; A Habr-Gama; B B Vailati; R O Perez
Journal: Tech Coloproctol Date: 2017-06-19 Impact factor: 3.781

5. Pre-operative radiotherapy to improve local control and survival in rectal cancer optimal time intervals between radiation and surgery.

Authors: Antonio Cassio Assis Pellizzon
Journal: Rep Pract Oncol Radiother Date: 2018-10-10

6. Clinical significance of VEGFR-2 and ¹⁸F-FDG PET/CT SUVmax pretreatment score in predicting the long-term outcome of patients with locally advanced rectal cancer treated with neoadjuvant therapy.

Authors: Claudio V Sole; Felipe A Calvo; Emilio Alvarez; Isabel Peligros; Pilar Garcia-Alfonso; Carlos Ferrer; Enrique Ochoa; Rafael Herranz; Jose L Carreras
Journal: Eur J Nucl Med Mol Imaging Date: 2013-06-26 Impact factor: 9.236

The 'good', the 'bad', and the 'ugly' rectal cancers.

1. Systemic Chemotherapy as Salvage Treatment for Locally Advanced Rectal Cancer Patients Who Fail to Respond to Standard Neoadjuvant Chemoradiotherapy.

2. Human cytomegalovirus and Epstein-Barr virus infection impact on (18)F-FDG PET/CT SUVmax, CT volumetric and KRAS-based parameters of patients with locally advanced rectal cancer treated with neoadjuvant therapy.

3. ¹⁸F-FDG PET/CT-based treatment response evaluation in locally advanced rectal cancer: a prospective validation of long-term outcomes.

4. The good, the bad and the ugly: rectal cancers in the twenty-first century.

5. Pre-operative radiotherapy to improve local control and survival in rectal cancer optimal time intervals between radiation and surgery.

6. Clinical significance of VEGFR-2 and ¹⁸F-FDG PET/CT SUVmax pretreatment score in predicting the long-term outcome of patients with locally advanced rectal cancer treated with neoadjuvant therapy.

Review 7. Selective use of radiation for locally advanced rectal cancer: one size does not fit all.

8. Stage and size using magnetic resonance imaging and endosonography in neoadjuvantly-treated rectal cancer.

9. Ezrin expression in rectal cancer predicts time to development of local recurrence.

Review 10. Advances and challenges in treatment of locally advanced rectal cancer.